【学術論文】（英文）

1. Takashi Mori, Masashi Mizumoto, Katsuya Maebayashi,Kentaro Nishioka, Yoshiki Arakawa, Kazuhiko Kurozumi, Koichi Yasuda1,Taisuke Sumiya, Hiroyasu Tamamura, Yoshitaka Sato, Takahiro Waki,Masaru Takagi, Yu Takada, Tomoaki Okimoto, Masao Murakami,Yasuhiro Kikuchi, Kazufumi Okada, Yoichi M. Ito, Tetsuo Akimoto and Hidefumi Aoyama : Proton beam therapy for gliomas: a multicenter prospective registry study from all proton beam facilities in Japan.. Journal of Radiation Research, 2023 Jun; 64(Suppl 1): i59–i68. Published online 2023 April 11, pp. 1–10 https://doi.org/10.1093/jrr/rrac103 PMCID: PMC10278883
2. Akimoto T, Aoyama H, Chua MLK, Jayamanne D, Mizowaki T, Morris L, Onishi H, Song SY, Zeidan YH, Sharma RA : Challenges and Opportunities With the Use of Hypofractionated Radiation Therapy in Cancer Care: Regional Perspectives From South Korea, Japan, Singapore, and Australia. Adv Radiat Oncol. 2023 Jun 14;8(6):101291. doi: 10.1016/j.adro.2023.101291. eCollection 2023 Nov-Dec. PMID: 37457823
3. Tatebe H, Harada H, Mori K, Iwata H, Akimoto T, Murakami M, Waki T, Ogino T, Nakamura M, Taguchi H, Nakayama H, Satouchi M, Aoyama H : Clinical results of proton beam radiotherapy for inoperable stage III non-small cell lung cancer: a Japanese national registry study. J Radiat Res. 2023 Jun 16;64(Supplement_1):i8-i15. doi: 10.1093/jrr/rrad017. PMID: 37137157
4. Ishikawa H, Arimura T, Maruo K, Kawamura H, Toyama S, Ogino T, Okimoto T, Murakami M, Sato Y, Nishioka K, Araya M, Ohba H, Umehara K, Aoyama H, Obara W, Azuma H, Tsuji H, Sakurai H : A Japanese registry study and systematic review of particle therapy for renal cell carcinoma. J Radiat Res. 2023 Jun 16;64(Supplement_1):i41-i48. doi: 10.1093/jrr/rrad010. PMID: 37045797
5. Kinoshita R, Mitamura T, Kato F, Hattori T, Higaki H, Takahashi S, Fujita Y, Otsuka M, Koizumi F, Uchinami Y, Mori T, Nishioka K, Hashimoto T, Ito YM, Watari H, Aoyama H : Distribution of human papilloma virus genotypes and treatment outcomes in definitive radiotherapy for cervical cancer. J Radiat Res. 2023 Mar 23;64(2):463-470. doi: 10.1093/jrr/rrac086. PMID: 36596754
6. Maeda Y, Kobashi K, Sato Y, Tamamura H, Yamamoto K, Matsushita K, Sasaki M, Tatebe H, Asahi T, Matsumoto S, Takamatsu S, Miyazaki K, Fujimoto R, Uchinami Y, Katoh N, Aoyama H : Effectiveness of CT-image guidance in proton therapy for liver cancer and the importance of daily dose monitoring for tumors and organs at risk. Med Phys. 2023 Jun;50(6):3274-3288. doi: 10.1002/mp.16433. Epub 2023 Apr 26. PMID: 37099416
7. Yamazaki H, Shibuya K, Kimoto T, Suzuki M, Murakami M, Terashima K, Okimoto T, Iizumi T, Sakurai H, Wakatsuki M, Suzuki O, Katoh N, Arimura T, Ogino T, Takagi M, Araya M, Waki T, Matsumoto S, Ogino H, Fukumoto T, Ohtsuka M. Proton beam therapy for extrahepatic biliary tract cancer: Analysis with prospective multi-institutional patients’ registration database, Proton-Net. Clin Transl Radiat Oncol. 2023 May 3;41:100634. doi: 10.1016/j.ctro.2023.100634. PMID: 37234735; PMCID: PMC10206422.
8. Murayama S, Yamada S, Hiroshima Y, Takiyama H, Taguchi H, Kimoto T, Anzai M, Hagiwara Y, Yasui K, Mori K, Ishihara S, Ueno H, Shimizu S, Aoyama H, Tsuji H, Sakurai H : Particle beam therapy for pelvic recurrence of colorectal cancer: a registry data analysis in Japan and a systematic review. J Radiat Res. 2023 Jun 16;64(Supplement_1):i25-i33. doi: 10.1093/jrr/rrad024. PMID: 37117038
9. Araya M, Ishikawa H, Nishioka K, Maruo K, Asakura H, Iizumi T, Takagi M, Murakami M, Azuma H, Obara W, Aoyama H, Sakurai H : Proton beam therapy for muscle-invasive bladder cancer: A systematic review and analysis with Proton-Net, a multicenter prospective patient registry database. J Radiat Res. 2023 Jun 16;64(Supplement_1):i49-i58. doi: 10.1093/jrr/rrad027. PMID: 37185773
10. Aibe N, Ogino H, Wakatsuki M, Fujikawa K, Teramukai S, Fukumitsu N, Shiba S, Yamamoto N, Nomoto A, Ono T, Oguri M, Yamaguchi H, Numajiri H, Shibuya K, Okazaki S, Miyasaka Y, Okonogi N, Murata K, Tatebe H, Motegi A, Okimoto T, Yoshino T, Mandai M, Katoh N, Tsuji H, Sakurai H : Comprehensive analysis of Japanese nationwide cohort data of particle beam therapy for pulmonary, liver and lymph node oligometastases: particle beam therapy versus high-precision X-ray radiotherapy. J Radiat Res. 2023 Jun 16;64(Supplement_1):i69-i83. doi: 10.1093/jrr/rrad004. PMID: 37053162
11. Doi Y, Nagata Y, Matsumoto Y, Numata K, Sasaki R, Yamada T, Igaki H, Imagumbai T,            Katoh N,Yoshitake T, Shimizuguchi T, Fujioka D, Inoue M, Koide Y, Kimura T, Ito Y : Multicenter retrospective study of stereotactic body radiotherapy for patients with previously untreated initial small hepatocellular carcinoma. Hepatol Res. 2023 Aug;53(8):749-760. doi: 10.1111/hepr.13908. Epub 2023 Apr 25. PMID: 37036153
12. Kano S, Suzuki T, Yoshida D, Tsushima N, Hamada S, Yasuda K, Uchinami Y, Aoyama H,  Homma A. The superselective intra-arterial infusion of cisplatin and concomitant radiotherapy (RADPLAT) is effective for metastatic lymph nodes in head and neck squamous cell carcinoma. Int J Clin Oncol. 2023 Sep;28(9):1121-1128. doi: 10.1007/s10147-023-02363-5. Epub 2023 Jun 8. PMID: 37289379
13. Tsushima N, Kano S, Yasuda K, Suzuki T, Hamada S, Nakamaru Y, Suzuki M, Uchinami Y, Aoyama H, Homma A : Treatment outcomes of the patient with sinonasal mucosal melanoma: the role of endoscopic resection and postoperative radiotherapy. Int J Clin Oncol. 2023 Sep;28(9):1218-1226. doi: 10.1007/s10147-023-02368-0. Epub 2023 Jun 17. PMID: 37329441
14. Uchinami Y, Kanehira T, Nakazato K, Fujita Y, Koizumi F, Takahashi S, Otsuka M, Yasuda K, Taguchi H, Nishioka K, Miyamoto N, Yokokawa K, Suzuki R, Kobashi K, Takahashi K, Katoh N, Aoyama H : Predicting the daily gastrointestinal doses of stereotactic body radiation therapy for pancreatic cancer based on the shortest distance between the tumor and the gastrointestinal tract using daily computed tomography images.BJRopen. 2023 Oct 18;5(1):20230043.
15. Saito T, Shikama N, Takahashi T, Harada H, Ueno S, Notsu A, Shirato H, Yamada K, Uezono H, Koide Y, Kubota H, Yamasaki T, Ito K, Heianna J, Okada Y, Tonari A, Katoh N, Wada H, Ejima Y, Yoshida K, Kosugi T, Takahashi S, Komiyama T, Uchida N, Miwa M, Watanabe M, Nagakura H, Ikeda H, Asakawa I, Shigematsu N : Factors associated with quality of life in patients receiving palliative radiotherapy for bone metastases: a secondary cross-sectional analysis of data from a prospective multicenter observational study. Br J Radiol. 2023 Nov;96(1151):20230351. doi: 10.1259/bjr.20230351. Epub 2023 Oct 3. PMID: 37750858
16. Gensheimer MF, Gee H, Shirato H, Taguchi H, Snyder JM, Chin AL, Vitzthum LK, Maxim PG, Wakelee HA, Neal J, Das M, Chang DT, Kidd E, Hancock SL, Shultz DB, Horst KC, Le QT, Wong S, Brown E, Nguyen N, Liang R, Loo BW Jr, Diehn M : Individualized Stereotactic Ablative Radiotherapy for Lung Tumors: The iSABR Phase 2 Nonrandomized Controlled Trial. JAMA Oncol. 2023 Nov 1;9(11):1525-1534. doi: 10.1001/jamaoncol.2023.3495. PMID: 37707820
17. Yamaguchi H, Fukumitsu N, Numajiri H, Ogino H, Katoh N, Okimoto T, Suzuki M, Sakurai H. The Japanese nationwide cohort data of proton beam therapy for liver oligometastasis in esophagogastric cancer patients. J Radiat Res. 2023 Nov 21;64(6):926-932. doi: 10.1093/jrr/rrad066. PMID: 37697668; PMCID: PMC10665303.
18. Saito Y, Suzuki R, Miyamoto N, Sutherland KL, Kanehira T, Tamura M, Mori T, Nishioka K, Hashimoto T, Aoyama H. : A new predictive parameter for dose-volume metrics in intensity-modulated radiation therapy planning for prostate cancer: Initial phantom study. J Appl Clin Med Phys. 2023 Dec 25:e14250. doi: 10.1002/acm2.14250. Online ahead of print.PMID: 38146130
19. Uchinami Y, Yasuda K, Kano S, Otsuka M, Hamada S, Suzuki T, Tsushima N, Takahashi S, Fujita Y, Miyazaki T, Higaki H, Taguchi J, Shimizu Y, Sakashita T, Homma A, Aoyama H : Treatment outcomes of radiotherapy with concurrent weekly cisplatin in older patients with locally advanced head and neck squamous cell carcinoma. Discov Oncol. 2023 Dec 8;14(1):226. doi: 10.1007/s12672-023-00844-7. PMID: 38063923
20. Yusuke Uchinami , Naoki Miyamoto , Daisuke Abo , Ryo Morita , Koji Ogawa , Tatsuhiko Kakisaka , Ryusuke Suzuki , Tomohiko Miyazaki , Hiroshi Taguchi , Norio Katoh , Hidefumi Aoyama : Real-time tumor-tracking radiotherapy with SyncTraX for primary liver tumors requiring isocenter shift. J Radiat Res. 2024 Jan 19;65(1):92-99. doi: 10.1093/jrr/rrad088. PMID: 7996094
21. Dekura Y, Yasuda K, Minatogawa H, Uchinami Y, Tsushima N, Suzuki T, Kano S, Mori T, Nishioka K, Kobashi K, Katoh N, Homma A, Aoyama H : Daily fraction dose-adjusted radiotherapy policy to avoid prolonging the overall treatment time for early glottic squamous cell carcinoma: a single-institutional retrospective study. J Radiat Res. 2024 Jan 19;65(1):63-70. doi: 10.1093/jrr/rrad080. PMID: 37952082
22. Watanabe S, Hirata K, Magota K, Takenaka J, Wakabayashi N, Shinyama D, Yasuda K, Homma A, Kudo K : Comparative study of physiological FDG uptake in small structures between silicon photomultiplier-based PET and conventional PET. Ann Nucl Med. 2024 Feb;38(2):131-138. doi: 10.1007/s12149-023-01884-3. Epub 2023 Nov 9. PMID: 37943379
23. Nishioka K, Hashimoto T, Mori T, Uchinami Y, Kinoshita R, Katoh N, Taguchi H, Yasuda K,         Ito YM,Takao S, Tamura M, Matsuura T, Shimizu S, Shirato H, Aoyama H. A Single-Institution Prospective Study To Evaluate the Safety and Efficacy of Real- Time Image-Gated Spot-Scanning Proton Therapy (RGPT) for Prostate Cancer. Adv Radiat Oncol. 2024 Feb 8;9(5):101464. doi: 10.1016/j.adro.2024.101464. eCollection 2024 May.PMID: 38560429
24. Uchinami Y, Yasuda K, Minatogawa H, Dekura Y, Nishikawa N, Kinoshita R, Nishioka K,        Katoh N,Mori T, Otsuka M, Miyamoto N, Suzuki R, Kobashi K, Shimizu Y, Taguchi J, Tsushima N, Kano S, Homma A, Aoyama H : Impact of adaptive radiotherapy on survival in locally advanced nasopharyngeal carcinoma treated with concurrent chemoradiotherapy. Radiat Oncol J. 2024 Mar;42(1):74-82. doi: 10.3857/roj.2023.00374. Epub 2024 Mar 18. PMID: 38549386
25. Yoshimura T, Yamada R, Kinoshita R, Matsuura T, Kanehira T, Tamura H, Nishioka K, Yasuda K, Taguchi H, Katoh N, Kobashi K, Hashimoto T, Aoyama H : Probability of normal tissue complications for hematologic and gastrointestinal toxicity in postoperative whole pelvic radiotherapy for gynecologic malignancies using intensity-modulated proton therapy with robust optimization. J Radiat Res. 2024 Mar 17:rrae008. doi: 10.1093/jrr/rrae008. Online ahead of print. PMID: 38499489
26. Mizumoto M, Ogino H, Okumura T, Terashima K, Murakami M, Ogino T, Tamamura H,    Akimoto T, Waki T, Katoh N, Araya M, Onoe T, Takagi M, Iwata H, Numajiri H, Okimoto T, Uchinami Y, Maruo K, Shibuya K, Sakurai H :  Proton Beam Therapy for Hepatocellular Carcinoma: Multicenter Prospective Registry Study in Japan. Int J Radiat Oncol Biol Phys. 2024 Mar 1;118(3):725-733. doi: 10.1016/j.ijrobp.2023.09.047. Epub 2023 Sep 30.PMID: 37778422
27. Yasuda K, Uchinami Y, Kano S, Taguchi J, Kawakita D, Kitayama M, Nishioka K, Mori T, Koizumi F, Fujii Y, Shimizu Y, Kobashi K, Yoshimoto S, Nibu KI, Homma A, Aoyama H : Radiotherapy with or without chemotherapy for locally advanced head and neck cancer in elderly patients: analysis of the Head and Neck Cancer Registry of Japan. Int J Clin Oncol. 2024 Mar;29(3):241-247. doi: 10.1007/s10147-023-02450-7. Epub 2023 Dec 29. PMID: 38155239
28. Suimon Y, Kase S, Kinoshita R, Ishida:　Clinicopathoogic features of conjunctival MALT lymphomas refractory for radiation therapy. Can J Ophtalmol.2023 Dec 12:S00008-4182 (23)00368-X

【国際共同研究】

1. Chopra S, Gupta A, Aoyama H, Wu HG, Mahmood H, Tharavichitkul E, Khine A, Gandhi A, Faruque GM, Cruz M, Kodrat H, Xue X, Abeysinghe P, Ho GF, Minjgee M, Tey J, Gao X: Radiation Oncology Research in Asia: Current Status and a Peep Into the Future From the Federation of Asian Organizations for Radiation Oncology. JCO Glob Oncol. 2023 Jun;9:e2300002. doi: 10.1200/GO.23.00002.PMID: 37384859
2. Pivotal, Randomized, Open-label Study of Optune® (Tumor Treating Fields) Concomitant With RT & TMZ for the Treatment of Newly Diagnosed GBM (EF-32) ClinicalTrials.gov Identifier: NCT04471844
3. Update of the Graded Prognostic Assessment (GPA) with molecular markers to estimate survival for patients with brain metastases

【総説】（英文）

1. Nishioka K, Takahashi S, Mori T, Uchinami Y, Yamaguchi S, Kinoshita M, Yamashina M, Higaki H, Maebayashi K, Aoyama H : The need of radiotherapy optimization for glioblastomas considering immune responses. Jpn J Radiol. 2023 Apr 18. doi: 10.1007/s11604-023-01434-x. Online ahead of print. PMID: 37071249 Review.
2. Homma A, Ando M, Hanai N, Harada H, Honma Y, Kanda T, Kano S, Kawakita D, Kiyota N, Kizawa Y, Nakagawa M, Ogawa T, Shinomiya H, Shinozaki T, Suzuki M, Tsuji T, Yasuda K, Zenda S, Kodaira T, Kirita T, Nibu KI : Summary of Japanese clinical practice guidelines for head and neck cancer – 2022 update edited by the Japan society for head and neck cancer. Auris Nasus Larynx. 2024 Feb;51(1):174-188. doi: 10.1016/j.anl.2023.07.003. Epub 2023 Jul 21.PMID: 37482431 Review.

【症例報告】（英文）

1. Mizushima, M., Okamoto, M., Yamaguchi, S., Oki, S., Motegi, H., Sugiyama, M., Manabe, A., Shimizu, A., Nishioka, K., Hashimoto, T., Hirato, J., Kanemura, Y., & Fujimura, M. (2023). Slow-growing WNT medulloblastoma with atypical magnetic resonance imaging findings: illustrative case. Journal of Neurosurgery. Case Lessons, 6(7). https://doi.org/10.3171/CASE23277

【総説・著書・その他】（英文）

1. Naoki Miyamoto, Norio Katoh, Hiroshi Taguchi, Kentaro Nishioka, Hidefumi Aoyama：Real-Time Tumor-Tracking Radiotherapy (RTRT), SyncTrax. P243-53. (Yasushi Nagata, Stereotactic Body Radiation Therapy Principles and Practices, Springer Nature), 2023

【学会発表】（国際学会）

1. Hashimoto Takayuki : Invited speaker「Proton therapy for pediatric brain tumor」 The 2023 Summer International Scientific Symposium of the Tiwan pediatric Brain Tumor Consortium(TPBTC) 2023.6.10 Taipei
2. Aoyama Hidefumi : Invited speaker「SRS for Brain metastasis」FARO＆KOSRO2023 symposium, Seoul,2023.10.11-13
3. Uchinami Yusuke :Speaker Results from FARO Patterns of Care Surveys「FERN Brain 　　Metastasisi Survey」FARO＆KOSRO2023 symposium, Seoul,2023.10.11-13
4. Shuhei Takahashi : Oral Session「Prognosis of patients with lymphopenia who undergo postoperative chemoradiotherapy for glioblastoma」the 3rd International Congress of the Asian Oncology Society (AOS2023), Yokohama, Japan, 2023.10.19-21

―ポスター発表―

1. Yusuke Uchinami, Takahiro Kanehira, Keiji Nakazato, Yoshihiro Fujita, Fuki Koizumi, Shuhei Takahashi, Manami Otsuka, Koichi Yasuda, Hiroshi Taguchi, Kentaro Nishioka,
2. Naoki Miyamoto, Kohei Yokokawa, Ryusuke Suzuki, Keiji Kobashi, Keita Takahashi, Norio Katoh, Hidefumi Aoyama：Predicting the daily gastrointestinal doses of stereotactic body radiation therapy for pancreatic cancer based on the shortest distance between the tumor and the gastrointestinal tract using daily computed tomography images. ESTRO2023 12-16May 2023 Vienna, Austria.
3. T. Kanehira, H. Taguchi, N. Katoh, Y. Uchinami, T. Yoshimura, M. Tamura, R. Suzuki, T. Hashimoto, H. Aoyama : Effect of early fractional lymphocyte loss on lymphopenia probability models for NSCLC. ESTRO2023 12-16May 2023 Vienna, Austria.
4. F. Koizumi, N. Katoh, T. Kanehira, Y. Kawamoto, T. Nakamura,T. Kakisaka, Y. Uchinami, H. Taguchi,Y. Fujita, S. Takahashi, H. Higaki, K. Nishioka,K. Yasuda, R. Kinoshita, R. Suzuki, Miyamoto, I. Yokota, K. Kobashi, H. Aoyama : A risk prediction model for severe radiation induced lymphopenia in patients with pancreatic cancer treated with concurrent chemoradiotherapy. ASTRO2023 1-4 October 2023 San Diego USA.
5. N. Katoh, K. Nakazato, Y. Uchinami , T. Kanehira , S. Takahashi, F. Koizumi, H. Taguchi, K. Nishioka, K. Yasuda, M. Tamura ,S. Takao, N. Miyamoto, T. Matsuura, K. Kobashi, H. Aoyama: Evaluation of the possibility of dose realignment adaptation by shifting the isocenter in proton beam therapy for pancreatic cancer. ASTRO2023 1-4 October 2023 San Diego USA.